CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer

Clinical trial NCT07278986 · RECRUITING

Trial details

NCT number: NCT07278986
Sponsor: Abramson Cancer Center at Penn Medicine
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Endometrial Cancer Near Infrared Fluorescence Imaging CYTALUX (Pafolacianine) Injection Planned Diagnostic Laparoscopies

Start date: 2025-10-18
Primary completion: 2027-10-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.